Abstract
RNA interference allows selective gene silencing, and is widely used for functional analysis of individual genes in vertebrate cells and represents an attractive therapeutic option for treating central nervous system diseases. However, growing evidence exists that the expression of short hairpin RNAs (shRNAs) can trigger cellular immune response resulting in unspecific cellular phenotypes and severe side effects. We found that lentiviral vector (LV)-mediated expression of shRNAs in primary cortical cultures resulted in strong expression of the interferon-stimulated gene oligoadenylate synthetase 1 (Oas1), which was accompanied by accelerated apoptosis and substantial net neuron loss. Modification of the shRNA construct by implementing features of the naturally occurring microRNA-30 (miR-30) precursor avoided Oas1 induction in transduced primary cultures, whereby modification of the passenger strand seems to be a crucial feature to circumvent interferon-stimulated gene expression. This work represents the first experimental study showing that an miR-30-based shRNA construct prevents Oas1 pathway associated off-target effects, which we consider as an essential prerequisite for shRNA use in future gene therapeutic approaches.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Raoul C, Abbas-Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005; 11: 423–428.
Zimprich A, Biskup S, Leitner P, Farrer M, Lincoln S, Kachergus J et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004; 44: 601–607.
Brummelkamp TR, Bernards R, Agami R . A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.
Alvarez VA, Ridenour DA, Sabatini BL . Retraction of synapses and dendritic spines induced by off-target effects of RNA interference. J Neurosci 2006; 26: 7820–7825.
Cao W, Hunter R, Strnatka D, Mcqueen CA, Erickson RP . DNA constructs designed to produce short hairpin, interfering RNAs in transgenic mice sometimes show early lethality and an interferon response. J Appl Genet 2005; 46: 217–225.
Kariko K, Bhuyan P, Capodici J, Weissman D . Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor 3. J Immunol 2004; 172: 6545–6549.
Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11: 263–270.
Sledz CA, Holko M, De Veer MJ, Silverman RH, Williams BR . Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5: 834–839.
Pebernard S, Iggo RD . Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 2004; 72: 103–111.
Garcia-Sastre A, Biron CA . Type 1 Interferons and the virus–host relationship: a lesson in détente. Science 2006; 312: 879–882.
Boden D, Pusch O, Silbermann R, Lee F, Tucker L, Ramratnam B . Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 2004; 32: 1154–1158.
Zeng Y, Wagner EJ, Cullen BR . Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 2002; 9: 1327–1333.
Cullen BR . Induction of stable RNA interference in mammalian cells. Gene Therapy 2006; 13: 503–508.
Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O'Neill E, Meitinger T et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 2006; 15: 223–232.
Wiznerowicz M, Trono D . Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003; 77: 8957–8961.
Bauer M, Szulc J, Meyer M, Jensen CH, Abbas Terki T, Meixner A et al. Delta-like 1 participates in the specification of ventral midbrain progenitor-derived dopaminergic neurons. J Neurochem 2008; 104: 1101–1115.
MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A . The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006; 52: 587–593.
Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R . Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263–264.
Karpala AJ, Doran TJ, Bean AG . Immune responses to dsRNA: implications for gene silencing technologies. Immunol Cell Biol 2005; 83: 211–216.
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853–858.
Manche L, Green SR, Schmedt C, Mathews MB . Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol 1992; 12: 5238–5248.
McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 2008; 105: 5868–5873.
Simon P . Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 2003; 19: 1439–1440.
Acknowledgements
We thank Stephanie Schöffmann for excellent technical assistance and Dr Thomas Meitinger for helpful discussions. This work was supported by the NGFN (‘SMP-Human Brain’, FKZ-01GR0449 to MU). and by a KKF grant from the Technical University Munich (KKF-Project 8725151 to MB).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bauer, M., Kinkl, N., Meixner, A. et al. Prevention of interferon-stimulated gene expression using microRNA-designed hairpins. Gene Ther 16, 142–147 (2009). https://doi.org/10.1038/gt.2008.123
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/gt.2008.123
Keywords
This article is cited by
-
Long non-coding RNA LncKdm2b regulates cortical neuronal differentiation by cis-activating Kdm2b
Protein & Cell (2020)
-
The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions
Scientific Reports (2017)
-
MicroRNAs: short non-coding players in cancer chemoresistance
Molecular and Cellular Therapies (2014)
-
Optimization of Critical Hairpin Features Allows miRNA-based Gene Knockdown Upon Single-copy Transduction
Molecular Therapy - Nucleic Acids (2014)
-
LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25
Experimental & Molecular Medicine (2013)


